
Last updated: 3 months ago
Halozyme Therapeutics 8-K Report: Key Insights on February 11, 2025 Events
Explore Halozyme Therapeutics, Inc.'s 8-K filing from February 11, 2025, detailing crucial company updates, stock information, and significant events impacting shareholders.